Momenta Pharmaceuticals, Inc. (MNTA)

[DFRAI]

Jbog

Yes, that is what I am talking about....copaxone revenues, partnership revenues fueling the biosimilars and Ivig platform

What is your problem? You don't think that most of us know that there is risk involved in buying a development biotech company?

You ought to go find a board for treasury or cd to invest in and stop berating MNTA and other investors here about their choice.